Hydroxychloroquine: From malaria to autoimmunity

Ilan Ben-Zvi, Shaye Kivity, Pnina Langevitz, Yehuda Shoenfeld

Research output: Contribution to journalReview articlepeer-review

Abstract

Quinine was first recognized as a potent antimalarial agent hundreds of years ago. Since then, the beneficial effects of quinine and its more advanced synthetic forms, chloroquine and hydroxychloroquine, have been increasingly recognized in a myriad of other diseases in addition to malaria. In recent years, antimalarials were shown to have various immunomodulatory effects, and currently have an established role in the management of rheumatic diseases, such as systemic lupus erythematosus and rheumatoid arthritis, skin diseases, and in the treatment of chronic Q fever. Lately, additional metabolic, cardiovascular, antithrombotic, and antineoplastic effects of antimalarials were shown. In this review, we discuss the known various immunomodulatory mechanisms of antimalarials and the current evidence for their beneficial effects in various diseases and in potential novel applications.

Original languageEnglish
Pages (from-to)145-153
Number of pages9
JournalClinical Reviews in Allergy and Immunology
Volume42
Issue number2
DOIs
StatePublished - Apr 2012
Externally publishedYes

Keywords

  • Antimalarial
  • Chloroquine
  • Hydroxychloroquine
  • Lupus
  • Novel
  • Therapy

Fingerprint

Dive into the research topics of 'Hydroxychloroquine: From malaria to autoimmunity'. Together they form a unique fingerprint.

Cite this